Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Advanced Enzyme Technologies's PB Ratio or its related term are showing as below:
NSE:ADVENZYMES'
s PB Ratio Range Over the Past 10 Years
Min: 1.61 Med: 3.09 Max: 11.48
Current: 2.22
During the past 13 years, Advanced Enzyme Technologies's highest PB Ratio was 11.48. The lowest was 1.61. And the median was 3.09.
NSE:ADVENZYMES's PB Ratio is ranked worse than 60.79% of 1576
companies
in the Chemicals industry
Industry Median: 1.715
vs NSE:ADVENZYMES: 2.22
During the past 12 months, Advanced Enzyme Technologies's average Book Value Per Share Growth Rate was 14.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 16.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Advanced Enzyme Technologies was 39.30% per year. The lowest was 9.30% per year. And the median was 21.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Advanced Enzyme Technologies PB Ratio Related Terms
Advanced Enzyme Technologies PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ADVENZYMES vs LIN, SHW, ECL: PB Ratio Comparison
For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Enzyme Technologies PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Advanced Enzyme Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a PB Ratio of 2.22 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Advanced Enzyme Technologies and its competitors. This is 28% below median its historical median of 3.09. Over the past decade, Advanced Enzyme Technologies' PB Ratio has ranged from 1.61 to 11.48. According to the industry distribution chart, Advanced Enzyme Technologies ranks #958 out of 1576 companies in the Chemicals industry, placing it in the top 60.8%.
Is Advanced Enzyme Technologies' PB Ratio too high?
Advanced Enzyme Technologies' current PB Ratio of 2.22 is 28% below median its 10-year median of 3.09. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 11.48. The Chemicals industry median PB Ratio is 1.72. Advanced Enzyme Technologies' value of 2.22 is 29.4% above this industry median. Based on the distribution chart, Advanced Enzyme Technologies ranks #958 out of 1576 companies in the Chemicals industry, which is below the industry midpoint. Overall, Advanced Enzyme Technologies has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' PB Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Advanced Enzyme Technologies ranks #958 out of 1576 companies for PB Ratio. This places Advanced Enzyme Technologies in the lower half of its industry. The industry median PB Ratio is 1.72. Advanced Enzyme Technologies' value of 2.22 is 29.4% above this benchmark. Historically, Advanced Enzyme Technologies' own PB Ratio has ranged from 1.61 to 11.48 over the past decade. While the company's 10-year median is 3.09 vs. the industry median of 1.72, Advanced Enzyme Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.72, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Enzyme Technologies's current PB Ratio of 2.22 is 29.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Advanced Enzyme Technologies and its competitors. For the Chemicals industry, the median PB Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Enzyme Technologies's current PB Ratio is 2.22, which is 28% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.89, compared to a current price of ₹324.35 — trading 22.9% below its estimated fair value. The current PB Ratio is 2.22, which is 28% below median its 10-year median of 3.09 and 29.4% above the Chemicals industry median of 1.72. Advanced Enzyme Technologies' overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current PB Ratio is 2.22 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued.
The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89.
GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.
Key valuation signals for NSE:ADVENZYMES:
PB Ratio: 2.22 (28% below median its 10-year median of 3.09)
GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
Industry Position: 29.4% above the Chemicals median (#958 of 1576)
No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score
Get the complete analysis for NSE:ADVENZYMES
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ADVENZYMES has been successfully added to your 
